Search Query :
7PZS
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 2.45 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7PZS_A
7PZU
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 2.15 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7PZU_A
7PZV
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 1.92 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7PZV_A
7PZW
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7PZW_A
7PZX
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 2.39 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7PZX_A
7Q01
Lpxc inhibitors with fluoroproline as a novel zinc-binding group can serve as a novel class of antibiotic with activity against multidrug-resistant gram-negative bacteria Deposition Author(s): Lamers, M.B.A.C. , Leonard, P.M. , Pallin, T.D. , Ryan, M.D.
Date: 2021-10-13 Method: X-RAY DIFFRACTION Resolution: 2.01 Å Organism(s): Pseudomonas Aeruginosa (Strain Atcc 15692 / Dsm 22644 / Cip 104116 / Jcm 14847 / Lmg 12228 / 1C / Prs 101 / Pao1) Sequences Data: 7Q01_A
7QH1
Discovery and development of a novel inhaled antivirulence therapy for the treatment of pseudomonas aeruginosa infections in patients with chronic respiratory disease Deposition Author(s): Davies, D. , Leonard, P.M. , Pallin, T.D.
Date: 2021-12-10 Method: X-RAY DIFFRACTION Resolution: 2.74 Å Organism(s): Pseudomonas Aeruginosa Sequences Data: 7QH1_A , 7QH1_B , 7QH1_C , 7QH1_D
7QPF
Discovery of lu af11167, a phosphodiesterase 10a inhibitor clinical candidate Deposition Author(s): Langgard, M. , Leonard, P.M.
Date: 2022-01-04 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens Sequences Data: 7QPF_A , 7QPF_B
7QPM
Discovery of lu af11167, a phosphodiesterase 10a inhibitor clinical candidate Deposition Author(s): Langgard, M. , Leonard, P.M.
Date: 2022-01-05 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 7QPM_A , 7QPM_B
7QPQ
Discovery of lu af11167, a phosphodiesterase 10a inhibitor clinical candidate Deposition Author(s): Langgard, M. , Leonard, P.M.
Date: 2022-01-05 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 7QPQ_A , 7QPQ_B